Randomized phase III trial of benefit of additional cholecystectomy in total gastrectomy for gastric cancer patients

Randomized phase III trial of benefit of additional cholecystectomy in total gastrectomy for gastric cancer patients - Randomized phase III trial of benefit of additional cholecystectomy in total gastrectomy for gastric cancer patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009163

Enrollment

380

Registered

2012-10-25

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

cholecystectomy preservation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)total gastrectomy 2)curative (R0) resection 3)no severe disturbance of liver function and renal function 4)an age of 85 years or younger 5)writen informed consent

Exclusion criteria

Exclusion criteria: 1)non-curative (R1) resection 2)additional pancreatectomy, hepatectomy 3)severe complication such as interstitial pneumonia, uncontrolled DM, ischemic heart disease, cardiac failure 4)liver cirrhosis, active hapatitis 5)haemodialysis

Design outcomes

Primary

Measure	Time frame
Incidence of postoperative complications	—

Secondary

Measure	Time frame
Incidence of perioperative complications Postoperative weight loss Nutritive conditions	—

Countries

Japan

Contacts

Public ContactToshiyasu Ojima

Wakayama Medical University Second Department of Surgery

tojima@wakayama-med.ac.jp073-441-0613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026